FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, cosmetic industry, particularly to an agent for preventing and treating obesity. A pharmaceutical composition for preventing and treating obesity containing loosestrife (Lysimachiae foenum-graeci herba) extract as an active ingredient. The preparation for preventing and treating obesity containing the composition described above as an active ingredient. The cosmetic composition for preventing and treating obesity and relieving its symptoms. The agents described above are effective for preventing and treating obesity.
EFFECT: dietary foodstuff for preventing and treating obesity and relieving its symptoms.
6 cl, 6 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION CONTAINING MONEYWORT EXTRACT FOR PREVENTING AND TREATING METABOLIC DISORDERS | 2008 |
|
RU2481851C2 |
| COMPOSITION FOR PREVENTING AND TREATING CANCER CONTAINING AGG ALBUMEN WITH COPPER VITRIOL | 2009 |
|
RU2473353C1 |
| METHOD OF INHIBITING SUCTION AND/OR INCREASING LIPID RELEASE WITH USING D-PSICOSE | 2016 |
|
RU2725145C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY-RELATED DISEASES CONTAINING INSULINOTROPIC PEPTIDE CONJUGATE | 2008 |
|
RU2446816C2 |
| COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF OBESITY | 2002 |
|
RU2280468C2 |
| AGENT FOR INHIBITION OF VISCERAL FAT UPTAKE | 2006 |
|
RU2372920C2 |
| COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY AND ASSOCIATED METABOLIC DISORDERS | 2020 |
|
RU2763348C2 |
| COMPOSITION PROMOTING REGULATION OF TOTAL CHOLESTEROL AND LDL CHOLESTEROL AND/OR WEIGHT LOSS AND/OR THERMOGENESIS | 2008 |
|
RU2465787C1 |
| USING PHYTOECDYSONE AND PREPARING COMPOSITIONS FOR TREATING METABOLIC SYNDROME | 2008 |
|
RU2491083C2 |
| FAT CONTENT CONTROL | 2003 |
|
RU2346688C2 |
